Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.

Maria Francesca DonatoCristina MorelliRenato RomagnoliFederica InvernizziChiara MazzarelliRosa Maria IemmoloMarzia MontalbanoIlaria LenciSherrie BhooriGiulia PieriSonia BerardiPaolo CaraceniSilvia Martininull null

Published in: Liver international : official journal of the International Association for the Study of the Liver (2016)

In patients with suboptimal virological response at LT, a bridging SOF/R regimen helps avoiding post-transplant graft reinfection.

Keyphrases

hepatitis c virus
hiv infected
antiretroviral therapy
hiv infected patients
free survival
hepatitis c virus infection